Acasti Pharma reported CAD114.2M in Equity Capital and Reserves for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Acasti Pharma ACST:US C$ 114.2M 58.54M
Addus Homecare ADUS:US $ 558.05M 14M
Agile Therapeutics AGRX:US $ 10.68M 13.93M
Amarin AMRN:US $ 642.5M 2.83M
Bioscrip BIOS:US $ 1097.48M 40.87M
Genetic Technologies GENE:US $ 21.53M 4.05M
Pain Therapeutics PTIE:US $ 267.56M 8.91M